The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review
Abstract
Oxidative stress, manifested by protein oxidation, lipid peroxidation, DNA oxidation and 3-nitrotyrosine formation, among other indices, is observed in Alzheimer's disease (AD) brain. Amyloid beta-peptide (1-42) [Abeta(1-42)] may be central to the pathogenesis of AD. Our laboratory and others have implicated Abeta(1-42)-induced free radical oxidative stress in the neurodegeneration observed in AD brain. This paper reviews some of these studies from our laboratory. Recently, we showed both in-vitro and in-vivo that methionine residue 35 (Met-35) of Abeta(1-42) was critical to its oxidative stress and neurotoxic properties. Because the C-terminal region of Abeta(1-42) is helical, and invoking the i + 4 rule of helices, we hypothesized that the carboxyl oxygen of lle-31, known to be within a van der Waals distance of the S atom of Met-35, would interact with the latter. This interaction could alter the susceptibility for oxidation of Met-35, i.e. free radical formation. Consistent with this hypothesis, substitution of lle-31 by the helix-breaking amino acid, proline, completely abrogated the oxidative stress and neurotoxic properties of Abeta(1-42). Removal of the Met-35 residue from the lipid bilayer by substitution of the negatively charged Asp for Gly-37 abrogated oxidative stress and neurotoxic properties of Abeta(1-42). The free radical scavenger vitamin E prevented A(beta (1-42)-induced ROS formation, protein oxidation, lipid peroxidation, and neurotoxicity in hippocampal neurons, consistent with our model for Abeta-associated free radical oxidative stress induced neurodegeneration in AD. ApoE, allele 4, is a risk factor for AD. Synaptosomes from apoE knock-out mice are more vulnerable to Abeta-induced oxidative stress (protein oxidation, lipid peroxidation, and ROS generation) than are those from wild-type mice. We also studied synaptosomes from allele-specific human apoE knock-in mice. Brain membranes from human apoE4 mice have greater vulnerability to Abeta(1-42)-induced oxidative stress than brain membranes from apoE2 or E3, assessed by the same indices, consistent with the notion of a coupling of the oxidative environment in AD brain and increased risk of developing this disorder. Using immunoprecipitation of proteins from AD and control brain obtained no longer than 4h PMI, selective oxidized proteins were identified in the AD brain. Creatine kinase (CK) and beta-actin have increased carbonyl groups, an index of protein oxidation, and Glt-1, the principal glutamate transporter, has increased binding of the lipid peroxidation product, 4-hydroxy-2-nonenal (HNE). Abeta inhibits CK and causes lipid peroxidation, leading to HNE formation. Implications of these findings relate to decreased energy utilization, altered assembly of cytoskeletal proteins, and increased excitotoxicity to neurons by glutamate, all reported for AD. Other oxidatively modified proteins have been identified in AD brain by proteomics analysis, and these oxidatively-modified proteins may be related to increased excitotoxicity (glutamine synthetase), aberrant proteasomal degradation of damaged or aggregated proteins (ubiquitin C-terminal hydrolase L-1), altered energy production (alpha-enolase), and diminished growth cone elongation and directionality (dihydropyrimindase-related protein 2). Taken together, these studies outlined above suggest that Met-35 is key to the oxidative stress and neurotoxic properties of Abeta(1-42) and may help explain the apoE allele dependence on risk for AD, some of the functional and structural alterations in AD brain, and strongly support a causative role of Abeta(1-42)-induced oxidative stress and neurodegeneration in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress and mitochondrial dysfunction are prominent features of many neurodegenerative diseases including AD (Butterfield, 2002; Butterfield and Boyd-Kimball, 2018; Sharma and Kim, 2021).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
In the citing paper
“For the same reason, the Aβ insertion into the lipid bilayer of the neuronal plasma membrane induces lipid peroxidation in a direct manner (Butterfield, 2002).”
From Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes (2022) · cites this paper as Butterfield, 2002
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781
Cited by
Sorted by citations
Items 501–600 of 794
Tenório, T. D. S., Silva, A. M., Ramos, J. M., Buarque, C. D., & Felcman, J. (2012) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2012.12.019 · Cited by 18
Alcoholism: protein expression profiles in a human hippocampal model
Matsumoto, H., & Matsumoto, I. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.321 · Cited by 17
de Jager, M., Boot, M. V., Bol, J. G. J. M., Brevé, J. J. P., Jongenelen, C. A. M., Drukarch, B., & Wilhelmus, M. M. M. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12244 · Cited by 18
Interaction between Amyloid Beta Toxicity and the PI3K Pathway in Alzheimer’s Disease
Choi, H., & Koh, S. H. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000269 · Cited by 17
Shin, E., Lee, S. H., Sharma, N., Nguyen, B. T., Chung, Y. H., Kang, S. W., Nah, S.-Y., Lee, Y. J., Nabeshima, T., Jeong, J. H., et al. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1854455 · Cited by 17
Liu, C.-T., Wu, B.-Y., Hung, Y., Wang, L.-Y., Lee, Y.-Y., Lin, T., Lin, P.-Y., Chen, W.-F., Chiang, J., Hsu, S.-F., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19094 · Cited by 17
Bobba, A., Amadoro, G., Petragallo, V. A., Calissano, P., & Atlante, A. (2013) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.04.001 · Cited by 17
Current Concepts in the Prevention of Alzheimer's Disease
Sano, M. (2003) · CNS Spectrums · doi:10.1017/s1092852900019283 · Cited by 17
Fukui, K., Yachi, K., Yoshida, H., Tanji, K., Matsumiya, T., Hayakari, R., Tsuruga, K., Tanaka, H., & Imaizumi, T. (2017) · Neurosciences research · doi:10.1016/j.neures.2017.05.005 · Cited by 16
Morroni, F., Sita, G., Graziosi, A., Ravegnini, G., Molteni, R., Paladini, M. S., Dias, K. S. T., dos Santos, A. F., Viegas, C., Camps, I., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00658 · Cited by 17
Siddique, Y. H., Naz, F., Rahul, & Varshney, H. (2022) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2022.100120 · Cited by 19
Can size alone explain some of the differences in toxicity between β‐amyloid oligomers and fibrils?
Keshet, B., Yang, I. H., & Good, T. A. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22691 · Cited by 16
Lee, S. L., Thomas, P., & Fenech, M. F. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21811 · Cited by 17
Soodi, M., Dashti, A., Hajimehdipoor, H., Akbari, S., & Ataei, N. (2017) · PubMed Central · doi:10.22074/cellj.2016.4722 · Cited by 16
Francioso, A., Conrado, A. B., Blarzino, C., Foppoli, C., Montanari, E., Dinarelli, S., Giorgi, A., Mosca, L., & Fontana, M. (2020) · Molecules · doi:10.3390/molecules25040961 · Cited by 16
Liu, Z., Chen, H., Li, T., Xu, L., & Du, H. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12028 · Cited by 16
Villareal, M. O., Sasaki, K., Margout, D., Savry, C., Almaksour, Z., Larroque, M., & Isoda, H. (2016) · Cytotechnology · doi:10.1007/s10616-016-9980-3 · Cited by 17
Ueno, M. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001004 · Cited by 15
Liu, W., Rosenberg, G. A., Shi, H., Furuichi, T., Timmins, G. S., Cunningham, L. A., & Liu, K. J. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.03.029 · Cited by 16
On the hydroperoxyl radical scavenging activity of two Edaravone derivatives: mechanism and kinetics
Pérez‐González, A., & Galano, A. (2013) · Journal of Physical Organic Chemistry · doi:10.1002/poc.3082 · Cited by 15
Truran, S., Franco, D. A., Roher, A. E., Beach, T. G., Burciu, C., Serrano, G. E., Maarouf, C. L., Schwab, S., Anderson, J., Georges, J., et al. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.06.014 · Cited by 15
Estimation of Oxidative Stress and Survivorship in Drosophila
Nayak, N., & Mishra, M. (2019) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4939-9756-5_11 · Cited by 15
Li, X., Li, Q., Zhang, Y., Bai, Y., Cao, Y., Yang, Y., Zang, L., Huang, M., & Sui, R. (2021) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2021.103380 · Cited by 15
Estrés oxidativo, péptido β-amiloide y enfermedad de Alzheimer
Manzano‐León, N., & Mas‐Oliva, J. (2006) · Gaceta Médica de México · Cited by 16
Botanical Phenolics and Neurodegeneration
Sun, A. Y., Wang, Q., Simonyi, Á., & Sun, G. Y. (2011) · Oxidative stress and disease · doi:10.1201/b10787-16 · Cited by 15
Todd, K. L., Fossati, S., Ghiso, J. A., & Rostagno, A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.010 · Cited by 15
Jia, L., Ye, J., Haiyan, L., Wang, W., Zhou, C., Zhang, X., Xu, J., Wang, L., & Jia, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.005 · Cited by 15
Peng, L., Zhang, Z., Li, Q., Song, Z., Yan, C., & Ling, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39217 · Cited by 18
Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators
Morozov, A. V., Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen’ev, M. B., Sharova, N. P., Карпов, В. Л., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160491 · Cited by 14
Morey, T. M., Winick‐Ng, W., Seah, C., & Rylett, R. J. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00415 · Cited by 14
Emamghoreishi, M., Farrokhi, M. R., Amiri, A., & Keshavarz, M. (2019) · PubMed · doi:10.22038/ajp.2019.12385 · Cited by 14
Karimi-Sales, R., Ashiri, M., Hafizi, M., Kalanaky, S., Maghsoudi, A. H., Fakharzadeh, S., Maghsoudi, N., & Nazaran, M. H. (2020) · Pharmaceutical Research · doi:10.1007/s11095-020-2773-6 · Cited by 14
Molecular Dynamics of Lysozyme Amyloid Polymorphs Studied by Incoherent Neutron Scattering
Matsuo, T., Francesco, A. D., & Peters, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.812096 · Cited by 14
Acquired expression of mutant Mitofusin 2 causes progressive neurodegeneration and abnormal behavior
Ishikawa, K., Yamamoto, S., Hattori, S., Nishimura, N., Mito, T., Matsumoto, H., Miyakawa, T., & Nakada, K. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2139-18.2018 · Cited by 14
Hilgier, W., Łazarewicz, J. W., Strużyńska, L., Frontczak‐Baniewicz, M., & Albrecht, J. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.10.005 · Cited by 14
Purple Fibrils: A New Type of Protein Chromophore
Quiñones-Ruíz, T., Rosario-Alomar, M. F., Ruiz-Esteves, K. N., Shanmugasundaram, M., Grigoryants, V. M., Scholes, C. P., Lopez-Garriga, J. J., & Lednev, I. K. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b03056 · Cited by 14
Neogi, N., Choudhury, K. P., Hossain, I., Hossain, S., & Sazid, M. G. (2025) · doi:10.3390/eesp2025037001 · Cited by 15
Keshavarz, M., Farrokhi, M. R., & Amiri, A. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.069 · Cited by 13
Verbandt, S., Cammue, B. P. A., & Thevissen, K. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.06.003 · Cited by 13
Vascular dysfunction-associated with Alzheimer’s disease
Carelli‐Alinovi, C., Dinarelli, S., Girasole, M., & Misiti, F. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-168047 · Cited by 13
Cognition in Vascular Aging and Mild Cognitive Impairment
Tsentidou, G., Μoraitou, D., & Tsolaki, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190638 · Cited by 13
Oxidative Stress and Alzheimer’s Disease
Wu, Y., Xu, Q., & Song, W. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_197 · Cited by 14
Ammam, M., Zakai, U. I., Wilson, G. S., & Glass, R. S. (2010) · Pure and Applied Chemistry · doi:10.1351/pac-con-09-08-10 · Cited by 13
Sukhanova, A. V., Poly, S., Shemetov, A. A., Bronstein, I. B., & Nabiev, I. R. (2012) · Biopolymers · doi:10.1002/bip.22055 · Cited by 14
Uquillas, F. D., Jacobs, H. I. L., Hanseeuw, B. J., Marshall, G. A., Properzi, M. J., Schultz, A. P., LaPoint, M. R., Johnson, K. A., Sperling, R. A., & Vannini, P. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.10.034 · Cited by 14
Halim, M. A., Rosli, I. M., Jaafar, S. S. M., Ooi, H.-M., Leong, P. W., Shamsuddin, S., Najimudin, N., & Azzam, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.27.063107 · Cited by 13
COFFEE: A HEALTH FUEL-BLOT POPULAR DRINKING
Islam, M. T., de Alencar, M. V. O. B., Oliveira, G. A. L. D., da Mata, A. M. O. F., Silva, S. W. C., Paz, M. F. C. J., & Cavalcante, A. A. D. C. M. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 12
Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers
Maeba, R., Araki, A., & Fujiwara, Y. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.08.001 · Cited by 15
Adewusi, E. A., & Steenkamp, V. (2015) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(15)60810-6 · Cited by 12
The Antisense Transcriptome and the Human Brain
Mills, J. D., Chen, B. J., Ueberham, U., Arendt, T., & Janitz, M. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0694-3 · Cited by 13
Schisandra chinensis water extract protects ethanol‐induced neurotoxicity in Caenorhabditis elegans
Wu, Z., Li, K., Tian, X., Zhou, M., & Li, Z. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13249 · Cited by 12
Babušíková, E., Dobrota, D., Turner, A., & Nalivaeva, N. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921060067 · Cited by 14
Meta-Analysis on the Association Between the TF Gene rs1049296 and AD
Wang, Y., Xu, S., Liu, Z., Lai, C., Xie, Z., Zhao, C., Wei, Y., & Bi, J. Z. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100014931 · Cited by 12
Carelli‐Alinovi, C., Giardina, B., & Misiti, F. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3103 · Cited by 12
Saad, Y., Segal, D., & Ayali, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140009 · Cited by 12
DRUG DELIVERY NANOCARRIERS TO CROSS OF THE BLOOD-BRAIN BARRIER
Palazzo, C., Karim, R., Évrard, B., & Piel, G. (2016) · Open Repository and Bibliography (University of Liège) · doi:10.1016/b978-0-323-42866-8.00001-0 · Cited by 11
Sharma, S., Goyal, H., Joshi, S., Nehru, B., & Saini, A. (2023) · Advances in Redox Research · doi:10.1016/j.arres.2023.100060 · Cited by 11
Rahman, M. H., Bajgai, J., Sharma, S., Jeong, E., Goh, S. H., Jang, Y.-G., Kim, C.-S., & Lee, K. (2023) · Antioxidants · doi:10.3390/antiox12061241 · Cited by 11
Su, C.-F., Merlitz, H., Thalmann, F., Marques, C. M., & Sommer, J. (2019) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.8b11909 · Cited by 11
Drug-delivery nanocarriers to cross the blood–brain barrier
Palazzo, C., Karim, R., Évrard, B., & Piel, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42866-8.00010-1 · Cited by 11
Antioxidant activity of X-34 in synaptosomal and neuronal systems
Kański, J., Rukhsana Sultana, A., Klunk, W. E., & Butterfield, D. A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03369-9 · Cited by 11
Fernández, O., Oru, G. T., Viebahn-Hänsler, R., Cabreja, G. L., Espinosa, I. S., & Fernández, E. G. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1029805 · Cited by 10
Post-translational Activation of Glutamate Cysteine Ligase with Dimercaprol
McElroy, P. B., Hari, A. S., Day, B. J., & Patel, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.723700 · Cited by 10
Li, H., Tan, L., Yang, H., Pang, W., Xu, T., & Jiang, Y.-G. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1471251 · Cited by 10
Biomarkers in ROS and Role of Isoprostanes in Oxidative Stress
Chandra, M., Panchatcharam, M., & Miriyala, S. (2016) · InTech eBooks · doi:10.5772/64706 · Cited by 13
Trifunović, J., Borčić, V., Vukmirović, S., & Mikov, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.11.001 · Cited by 10
Therapeutic Approaches to Delay the Onset of Alzheimer's Disease
Kumar, R., & Atamna, H. (2011) · Journal of Aging Research · doi:10.4061/2011/820903 · Cited by 10
Koodalingam, A., Manikandan, R., Indhumathi, M., & Kaviya, E. S. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60300-x · Cited by 9
Maeba, R., Araki, A., Ishii, K., Ogawa, K., Tamura, Y., Yasunaga, M., Minami, U., Komori, A., Okazaki, T., Nishimukai, M., et al. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.12.007 · Cited by 9
Caspases: A Potential Therapeutic Targets in the Treatment of Alzheimer’s Disease
Jana, K. (2013) · Translational Medicine · doi:10.4172/2161-1025.s2-006 · Cited by 9
Mallozzi, C., Crestini, A., D’Amore, C., Piscopo, P., Cappella, M., Perrone, F., Talarico, G., Bruno, G., Vanacore, N., & Confaloni, A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.050 · Cited by 9
The Key Role of Membranes in Amyloid Formation from a Biophysical Perspective
Torres-Bugeau, C. M., Borsarelli, C. D., Minahk, C. J., & Chehín, R. N. (2011) · Current Protein and Peptide Science · doi:10.2174/138920311795860197 · Cited by 9
Biological properties of butanol extracts from green pine cone of Pinus densiflora
Lee, S., Kim, W.-B., Park, S. H., Kim, M., Kim, D., Park, J., Hwang, D. Y., & Lee, H. (2018) · Food Science and Biotechnology · doi:10.1007/s10068-018-0382-5 · Cited by 9
Molecular Determinants of Alzheimer’s Disease Aβ Peptide Neurotoxicity
Cappai, R., & Barnham, K. J. (2007) · Future Neurology · doi:10.2217/14796708.2.4.397 · Cited by 9
Emerging Therapeutics for Alzheimer's Disease: An Avenue of Hope
Samuels, S. C., & Grossman, H. T. (2003) · CNS Spectrums · doi:10.1017/s1092852900019271 · Cited by 9
Davies‐Jenkins, C. W., Workman, C. I., Hupfeld, K. E., Zöllner, H. J., Leoutsakos, J., Kraut, M. A., Barker, P. B., Smith, G. S., & Oeltzschner, G. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.06.003 · Cited by 8
Kakkar, A., Singh, H., Anand, A. K., Chopra, H., & Mishra, A. K. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128373290250620054118 · Cited by 8
Bertl, A., Brantl, V., Scherbaum, N., Rujescu, D., & Benninghoff, J. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02070-4 · Cited by 8
Antioxidants Mitigate Oxidative Stress: A General Overview
Umber, J., Qasim, M., Ashraf, S., Ashfaq, U. A., Mahmood-ur-Rahman, Iram, A., Bhatti, R., Tariq, M., & Masoud, M. S. (2023) · Food bioactive ingredients · doi:10.1007/978-3-031-41188-5_7 · Cited by 8
Ichiba, H., Nakamoto, M., Yajima, T., Takayama, M., & Fukushima, T. (2009) · Biomedical Chromatography · doi:10.1002/bmc.1262 · Cited by 8
Theoretical Study of the Reactivity and Selectivity of Various Free Radicals with Cysteine Residues
Romero-Silva, A., Mora‐Diez, N., & Alvarez-Idaboy, J. R. (2018) · ACS Omega · doi:10.1021/acsomega.8b02964 · Cited by 8
da Silva, G. F. Z., & Ming, L. (2007) · Angewandte Chemie · doi:10.1002/ange.200604421 · Cited by 8
Ahmed, A. R., Farris, F. F., & Ray, S. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00624-2 · Cited by 8
Ontawong, A., Nehra, G., Maloney, B. J., Vaddhanaphuti, C. S., Bauer, B., & Hartz, A. M. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094352 · Cited by 7
Upadhayay, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116285 · Cited by 7
Nitric Oxide and Cellular Stress Response in Brain Aging and Neurodegenerative Disorders
Calabrese, V., Mancuso, C., Marco, C. M. D., Stella, A. M. G., & Butterfield, D. A. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50145-9 · Cited by 7
Characterizing the novel protein p33MONOX
Mishra, M., Inoue, N., & Heese, K. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0690-4 · Cited by 7
Machhi, J., Prajapati, N. K., Tripathi, A., Parikh, Z. S., Kanhed, A. M., Patel, K. V., Pillai, P. P., Giridhar, R., & Yadav, M. R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0184-9 · Cited by 7
Dianas farmacológicas en las enfermedades neurodegenerativas
Segura, T., Galindo, M. F., Rallo, B., Callejo, V. C., & Bueso, J. J. (2003) · Revista de Neurología · doi:10.33588/rn.3611.2003230 · Cited by 7
Thome, J., & Eisch, A. J. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1775-7 · Cited by 7
Lee, M. (2008) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.128.753 · Cited by 7
Lopez, M. F., Mikulskis, A., Golenko, E. E., Melov, S., Bennett, D. A. A., Cherkasskiy, A., Kuzdzal, S. A., Kramer, S. M., & Sissors, D. (2004) · Electrophoresis · doi:10.1002/elps.200406011 · Cited by 7
Chen, L., Zhang, Z., Guan, Z., Sun, J., Sun, Y., Xu, M., Wong, K., Shi, G., & Ding, Z. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106146 · Cited by 6
Borkowski, K., Liang, N., Zhao, N., Arnold, M., Huynh, K., Karu, N., Mahmoudiandehkordi, S., Kueider-Paisley, A., Kanekiyo, T., Bu, G., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00888-z · Cited by 7
Kandpal, M., Varshney, N., Rawal, K. S., & Jha, H. C. (2024) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2024.02.001 · Cited by 6
Althobaiti, N. A., Menaa, F., Albalawi, A. E., Dalzell, J. J., Warnock, N. D., Mccammick, E. M., Alsolais, A., Alkhaibari, A. M., & Green, B. D. (2021) · Cells · doi:10.3390/cells10092481 · Cited by 7
Mitochondrial targeting of potent nanoparticulated drugs in combating diseases
Mandal, A. K. (2022) · Journal of Biomaterials Applications · doi:10.1177/08853282221111656 · Cited by 6
Dai, J., Ding, X., Miyahara, H., Xu, Z., Cui, X., Igarashi, Y., Sawashita, J., Mori, M., & Higuchi, K. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1263274 · Cited by 6
Qaid, E. Y. A., Long, I., Azman, K. F., Ahmad, A. H., Othman, Z., Sirajudeen, K. N. S., Ahmi, A., & Zakaria, R. (2021) · Journal of Cellular Neuroscience and Oxidative Stress · doi:10.37212/jcnos.946898 · Cited by 6
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease
Mittal, A., Sharma, R., Sardana, S., Goyal, P. K., Piplani, M., & Pandey, A. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220510144127 · Cited by 6
Metadata
- Authors
- Allan Butterfield, D.
- Venue
- Free Radical Research
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 36
- Issue
- 12
- Pages
- 1307-1313
- ISSN
- 1029-2470 (ISSN-L)
- 1071-5762
- OpenAlex
- W2153767421
- Cited by
- 786
- References
- 58
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 18 · 2023: 21 · 2022: 24 · 2021: 34 · 2020: 26 · 2019: 28 · 2018: 30 · 2017: 32 · 2016: 45 · 2015: 43 · 2014: 42 · 2013: 39 · 2012: 42
- FWCI
- 18.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Free Radical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Kentucky
- National Institute on Aging (P01AG010836, P01AG005119, AG 10836, AG12423, AG0 5119, R01AG012423)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid beta peptide 1-42, oxidative stress, neurotoxicity, Alzheimer's disease, protein oxidation, lipid peroxidation, nitrotyrosine, vitamin E, hippocampal neurons, synaptosomes, apolipoprotein E, APOE ε4, amyloid fibril formation, neurodegeneration, lipid bilayers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Humans, Lipid Bilayers, Methionine, Molecular Sequence Data, Neurons, Peptide Fragments, Peptides, Free Radical Scavengers, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Structure, Tertiary, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review